Sponsor Pipeline

Kunming Pharmaceuticals, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07279493 Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke Acute Ischemic Stroke Recruiting
NCT07557927 A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating… Discoid Lupus Erythematosus Not Yet Recruiting
Phase 1
NCT06867406 A Trial to Evaluate KPC000154 Tablets in Healthy Subjects Healthy Subjects、Lipid Metabolism Not Yet Recruiting
NCT07422142 A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic… Delirium Not Yet Recruiting
Disease Areas
Stroke (1) Lupus (SLE) (1)
Get alerts when Kunming Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free